Contributes Expertise in Clinical Genome Interpretation in order to Advance Genomic Medicine
May 20, 2014 – Tute Genomics has announced that they will join the Global Alliance for Genomics and Health, a group of the world's leading genomics and healthcare organizations with a shared mission to accelerate the sharing of genomic data for healthcare by developing ethical and secure standards. As a partner with the Global Alliance, Tute will work to meet the group's goal of accelerating worldwide efforts to responsibly share and analyze large amounts of genomic and clinical data.
As the foremost experts in annotation of personal genomes, including Kai Wang, Ph.D., the architect of ANNOVAR, Tute Genomics will contribute both gold standard and novel technologies for the rapid identification of disease-causing variants. These elements of data interpretation are highly valuable to the Alliance's mission of establishing a standardized approach of best practices in data sharing.
"We are excited to take part in the Global Alliance for Genomics and Health and share the vision of accelerating progress in genomic medicine and foster a collaborative culture of innovation and discovery," stated Reid Robison, M.D., CEO of Tute Genomics. "From day one, our genome interpretation platform has supported secure and responsible sharing of data among researchers to enable more efficient genetic research and make a positive impact on human health."
Global Alliance partners are focused on promoting the highest standards for ethics and ensuring that individuals are able to responsibly and securely share their genomic and clinical information. The Alliance and its partners aim to create a cooperative system in which organizations can aggregate and analyze the growing wealth of genetic information on a large scale, in order to expand the knowledge base that is necessary for effective diagnosis and targeted treatment of cancers, inherited diseases, and infectious diseases.
"With the help of Tute Genomics, the Global Alliance for Genomics and Health will continue to collaborate on ideas, identify and establish best practices, and enable interoperability," said Peter Goodhand, Acting Executive Director of the Global Alliance for Genomics and Health.